Epitope-targeted vaccines for HIV-1 prevention

Ended Project Grant Awarded Last action

Award ID
P01AI100151
Recipient
Awarding agency
Obligated
$15,391,986

Award facts

Assistance listing
93.855 Allergy and Infectious Diseases Research
Completion date
Originally
Place of performance
New York, NY 10016, USA

Award details come from USAspending.gov.

Transactions

Action Obligated Date
Amendment -$6,561
Amendment $2,525,880
Amendment -$655,634
Amendment $655,634
Amendment $421,594
Amendment $2,580,983
Amendment $2,816,030
Amendment $2,135,189
Amendment $125,000
Amendment $2,407,157
Original award $2,386,714
Show all 11

Subawards

Subrecipient Amount Awarded
Oregon Health & Science University The goal of the macaque core for this P01 project is to provide expertise and nonhuman primates to determine the immunogenicity of novel HIV vaccines. They will… $1,049,298
Icahn School Of Medicine At Mount Sinai $2,750,456
Molsoft L.L.C. $400,000
University Of Massachusetts Medical School Design HIV-1 envelope glycoprotein(Env)-derived immunogens capable of inducing antibodies with anti-viral activities against diverse isolates of HIV-1 remains… $1,856,705

Quick answers

Who received award P01AI100151?

P01AI100151 was awarded to New York University by National Institute of Allergy and Infectious Diseases (National Institutes of Health) on August 15, 2012.

How much is award P01AI100151 worth?

$15,391,986 has been obligated on P01AI100151.

On GovTribe

See this award's full record

  • Every transaction and subaward
  • The recipient's other awards and teaming partners
  • Similar grant awards
  • Ask GovTribe AI about this award
Try for free Login